BACKGROUND/AIMS: The prevalence of dementia and cognitive impairment not dementia was investigated in the Caerphilly Prospective Study cohort (men currently aged 65-84 years). METHODS: Of 1,633 men eligible for cognitive screening, 1,225 (75%) were seen, with those failing the screening criteria (CAMCOG <83 or decline in CAMCOG >9) being neurologically examined. RESULTS: For dementia, diagnosed by DSM-IV criteria, the population prevalence was 5.2% rising to 6.1% in the screened population. For cognitive impairment not dementia, the prevalence in the screened population was 15.6% giving an overall prevalence of cognitive impairment of 21.8%. Prevalence rose fivefold between ages of 65 and 84 years to reach over 50%. CONCLUSION: These figures are likely to underestimate actual prevalence in this population, and developing effective interventions should be a public health priority. (c) 2008 S. Karger AG, Basel.
BACKGROUND/AIMS: The prevalence of dementia and cognitive impairment not dementia was investigated in the Caerphilly Prospective Study cohort (men currently aged 65-84 years). METHODS: Of 1,633 men eligible for cognitive screening, 1,225 (75%) were seen, with those failing the screening criteria (CAMCOG <83 or decline in CAMCOG >9) being neurologically examined. RESULTS: For dementia, diagnosed by DSM-IV criteria, the population prevalence was 5.2% rising to 6.1% in the screened population. For cognitive impairment not dementia, the prevalence in the screened population was 15.6% giving an overall prevalence of cognitive impairment of 21.8%. Prevalence rose fivefold between ages of 65 and 84 years to reach over 50%. CONCLUSION: These figures are likely to underestimate actual prevalence in this population, and developing effective interventions should be a public health priority. (c) 2008 S. Karger AG, Basel.
Authors: Samuel Thomas Creavin; John Gallacher; Janet Pickering; Ann Fehily; Mark Fish; Shah Ebrahim; Antony Bayer; Yoav Ben-Shlomo Journal: Eur J Epidemiol Date: 2012-03-06 Impact factor: 8.082
Authors: Belina Nunes; Ricardo D Silva; Vitor T Cruz; Jose M Roriz; Joana Pais; Maria C Silva Journal: BMC Neurol Date: 2010-06-11 Impact factor: 2.474
Authors: Peter Elwood; Julieta Galante; Janet Pickering; Stephen Palmer; Antony Bayer; Yoav Ben-Shlomo; Marcus Longley; John Gallacher Journal: PLoS One Date: 2013-12-09 Impact factor: 3.240